{"id":63520,"title":"Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy.","abstract":"","date":"2014-07-09","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24429497","annotations":[{"name":"Therapy","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Multiple myeloma","weight":0.720698,"wikipedia_article":"http://en.wikipedia.org/wiki/Multiple_myeloma"},{"name":"Combination therapy","weight":0.551844,"wikipedia_article":"http://en.wikipedia.org/wiki/Combination_therapy"},{"name":"Bortezomib","weight":0.116968,"wikipedia_article":"http://en.wikipedia.org/wiki/Bortezomib"},{"name":"Carfilzomib","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Carfilzomib"}]}
